H. Wedemeyer Et Al. , "BASELINE ALT LEVELS BUT NOT HDV-RNA LEVELS ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT OF DELTA HEPATITIS: DATA FROM THE HIDIT-1 TRIAL," 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , vol.48, San-Francisco, Costa Rica, 2008
Wedemeyer, H. Et Al. 2008. BASELINE ALT LEVELS BUT NOT HDV-RNA LEVELS ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT OF DELTA HEPATITIS: DATA FROM THE HIDIT-1 TRIAL. 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , (San-Francisco, Costa Rica).
Wedemeyer, H., Yurdaydin, C., Zachou, K., Erhardi, A., Cakaloglu, Y., YALÇIN, K., ... Gurel, S.(2008). BASELINE ALT LEVELS BUT NOT HDV-RNA LEVELS ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT OF DELTA HEPATITIS: DATA FROM THE HIDIT-1 TRIAL . 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Costa Rica
Wedemeyer, Heiner Et Al. "BASELINE ALT LEVELS BUT NOT HDV-RNA LEVELS ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT OF DELTA HEPATITIS: DATA FROM THE HIDIT-1 TRIAL," 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Costa Rica, 2008
Wedemeyer, Heiner Et Al. "BASELINE ALT LEVELS BUT NOT HDV-RNA LEVELS ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT OF DELTA HEPATITIS: DATA FROM THE HIDIT-1 TRIAL." 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , San-Francisco, Costa Rica, 2008
Wedemeyer, H. Et Al. (2008) . "BASELINE ALT LEVELS BUT NOT HDV-RNA LEVELS ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT OF DELTA HEPATITIS: DATA FROM THE HIDIT-1 TRIAL." 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , San-Francisco, Costa Rica.
@conferencepaper{conferencepaper, author={Heiner Wedemeyer Et Al. }, title={BASELINE ALT LEVELS BUT NOT HDV-RNA LEVELS ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT OF DELTA HEPATITIS: DATA FROM THE HIDIT-1 TRIAL}, congress name={59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases}, city={San-Francisco}, country={Costa Rica}, year={2008}}